PHOENIX, May 29, 2015 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Valmie Resources (OTCBB:VMRI), EKSO BIONICS (OTCBB:EKSO), NuGene (OTCBB:NUGN), Titan Pharmaceuticals (OTCMKTS:TTNP), Medican (OTCMKTS:MDCN), and Auri (OTCMKTS:AURI).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Valmie Resources Inc (OTCBB:VMRI): By the end of last trading, Valmie Resources (OTCBB:VMRI) shares declined 27.21% (or US$0.171) to US$0.456 with about 0.968 million shares exchanging hands for the session, compared to its average volume of 0.179 million shares. During the past months, the company stock dropped from US$3 per share to around US$0.5 per share today. According to its latest financial report, the company has US$5 thousand cash on hand, but had no revenues for last quarter. The company sold large amounts of heavily discounted stocks a few years ago, including it issued about 59 million shares of common stock for only US$10 thousand. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report Mere.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/052915A/VMRI/ValmieResources.pdf
EKSO BIONICS HOLDING (OTCBB:EKSO): By the end of last trading, the EKSO BIONICS (OTCBB:EKSO) shares earned 2.86% (or US$0.05) to US$1.80 with about 0.623 million shares exchanging hands for the session, compared to its average volume of 0.759 million shares. According to its financial report, there's US$21.13 million cash on hand that can support its operations well. Last quarter, it generated US$1.68 million revenues with the final net loss about US$4.11 million. On May 20, the company announced it secured a third contract with the United States Special Operations Command (SOCOM) to work on the next phase of the Tactical Assault Light Operator Suit (TALOS) project. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/052915A/EKSO/EKSOBIONICS.pdf
NuGene International Inc (OTCBB:NUGN): By the end of last trading, NuGene (OTCBB:NUGN) shares rose 2.37% (or US$0.08) to US$3.45 with about 1.56 million shares exchanging hands for the session, compared to its average volume of 0.154 million shares. The shareholders purchased 148,200 shares for US$37,050 on March 7, 2014. A few weeks later, the company executed a 5 for 1 forward split which means that these shareholders returned their 148,200 pre-split shares and received 741,000 post-split ones. Fast forward a few more months, and you arrive at the name change and change in control. Another forward split was executed in January 2015, this time a 15.04 for 1, and the shareholders were once again forced to return their holdings. In exchange, they received 11,144,640 shares. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/052915A/NUGN/NuGene.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time foFr insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Titan Pharmaceuticals, Inc. (OTCMKTS:TTNP):
Medican Enterprises Inc (OTCMKTS:MDCN):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/052915A/MDCN/Medican.pdf
Auri Inc. (OTCMKTS:AURI):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/052915A/AURI/Auri.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.